BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. (BBIO) — SEC Financial Statements & Analysis
BridgeBio Pharma, Inc. (BBIO) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
One Point Seven Five Percentage Convertible Senior… | - | - | - | 559 | 5 | - | - | - | - | - | - | - | |||||
Two Point Two Five Percentage Convertible Senior N… | - | - | - | 1 | 739 | 748 | -0 | 0 | 0 | 737 | 0 | 0 | |||||
Two Point Five Zero Percentage Convertible Senior … | - | - | - | -4 | 550 | 34 | -0 | 0 | 0 | 543 | 0 | 0 | |||||
A2033 Convertible Senior Notes | 620 | - | - | - | 0 | - | - | - | - | - | - | - | |||||
A2031 Convertible Senior Notes | 565 | 565 | 564 | - | 575 | 0 | - | - | - | - | - | - | |||||
A2029 Convertible Senior Notes | 741 | 741 | 740 | - | 0 | 739 | 0 | - | - | - | - | - | |||||
A2027 Convertible Senior Notes | 547 | 547 | 547 | - | 0 | 545 | 0 | - | - | - | - | - | |||||
Term Loan | - | 0 | 0 | - | - | 437 | - | - | - | - | - | - | |||||
Equity Securities Fv Ni | - | - | - | - | - | 0 | 0 | 0 | 0 | 59 | 38 | 50 | |||||
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 880 | 570 | 643 | 749 | 541 | 681 | 266 | 408 | 475 | 376 | 505 | 302 | |||||
Receivables Long Term Contracts Or Programs | - | - | - | - | - | - | 0 | 1 | 235 | 2 | 5 | 9 | |||||
Restricted Cash Current | - | 1 | - | - | - | 0 | 139 | 139 | 0 | 17 | 17 | 20 | |||||
Available For Sale Securities Debt Securities Curr… | 60 | 17 | 3 | 8 | - | 0 | - | 40 | 44 | 0 | 0 | 31 | |||||
Accounts Receivable Net Current | 205 | 139 | 117 | 77 | 115 | 5 | - | - | - | 2 | - | - | |||||
Inventory Net | 33 | 27 | 25 | 18 | 4 | 0 | - | - | - | - | - | - | |||||
Prepaid Expense And Other Assets Current | 63 | 44 | 52 | 60 | 35 | 35 | 38 | 28 | 28 | 24 | 23 | 21 | |||||
Assets Current | 1,241 | 798 | 839 | 912 | 695 | 721 | 445 | 616 | 783 | 478 | 588 | 433 | |||||
Investments In Affiliates Subsidiaries Associates … | - | - | 92 | 108 | 128 | 144 | 160 | 117 | - | 0 | - | - | |||||
Equity Method Investments | 62 | 80 | - | - | - | 144 | - | - | - | - | - | - | |||||
Property Plant And Equipment Net | 5 | 5 | 6 | 6 | 7 | 7 | 9 | 10 | 11 | 12 | 12 | 13 | |||||
Operating Lease Right Of Use Asset | 17 | 8 | 7 | 6 | 7 | 6 | 6 | 7 | 8 | 8 | 9 | 10 | |||||
Intangible Assets Net Excluding Goodwill | 27 | 28 | 29 | 30 | 28 | 24 | 25 | 25 | 26 | 26 | 27 | 28 | |||||
Other Assets Noncurrent | 19 | 17 | 26 | 18 | 17 | 18 | 20 | 19 | 21 | 23 | 19 | 20 | |||||
Assets | 1,371 | 936 | 998 | 1,080 | 882 | 919 | 665 | 794 | 849 | 546 | 655 | 504 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 29 | 36 | 19 | 26 | 28 | 10 | 13 | 18 | 5 | 11 | 4 | 4 | |||||
Employee Related Liabilities Current | 39 | 77 | 56 | 37 | 33 | 58 | 44 | 29 | 32 | 57 | 34 | 29 | |||||
Operating Lease Liability Current | 4 | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | |||||
Deferred Revenue Current | - | - | - | 11 | 12 | 15 | 12 | 15 | 14 | 6 | 7 | 6 | |||||
Contract With Customer Liability Current | 6 | 7 | 9 | - | - | 15 | - | - | - | - | - | - | |||||
Other Liabilities Current | 136 | 120 | 93 | 66 | 41 | 33 | - | - | - | - | - | - | |||||
Liabilities Current | 816 | 288 | 217 | 176 | 152 | 154 | 139 | 134 | 141 | 144 | 106 | 110 | |||||
Long Term Debt Noncurrent | - | - | - | 0 | 0 | 437 | 436 | 435 | 435 | 446 | 442 | 440 | |||||
Operating Lease Liability Noncurrent | 14 | 4 | 3 | 4 | 5 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | |||||
Deferred Revenue Noncurrent | - | - | - | 15 | 18 | 17 | 19 | 17 | 20 | 4 | - | - | |||||
Contract With Customer Liability Noncurrent | 12 | 13 | 13 | - | - | 17 | - | - | - | - | - | - | |||||
Other Liabilities Noncurrent | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 6 | 12 | 13 | |||||
Liabilities | 3,640 | 3,013 | 2,921 | 2,859 | 2,520 | 2,377 | 1,883 | 1,876 | 1,886 | 1,889 | 1,849 | 1,853 | |||||
Stockholders Equity | |||||||||||||||||
Preferred Stock Value | 0 | 0 | 0 | - | 0 | 0 | - | - | - | - | - | - | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Treasury Stock Value | - | - | - | -323 | -323 | -275 | -275 | -275 | -275 | -275 | -275 | -275 | |||||
Treasury Stock Common Value | -406 | -323 | -323 | - | - | -275 | - | - | - | - | - | - | |||||
Additional Paid In Capital | 2,112 | 2,058 | 2,018 | 1,981 | 1,938 | 1,903 | 1,876 | 1,851 | 1,821 | 1,481 | 1,460 | 1,128 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | |||||
Retained Earnings Accumulated Deficit | -3,985 | -3,821 | -3,628 | -3,446 | -3,264 | -3,096 | -2,831 | -2,669 | -2,596 | -2,561 | -2,392 | -2,215 | |||||
Stockholders Equity | -2,268 | -2,087 | -1,933 | -1,788 | -1,638 | -1,468 | -1,230 | -1,093 | -1,050 | -1,354 | -1,195 | -1,362 | |||||
Minority Interest | 10 | 11 | 10 | 10 | 10 | 10 | 11 | 11 | 12 | 11 | 12 | 12 | |||||
Liabilities And Stockholders Equity | 1,371 | 936 | 998 | 1,080 | 882 | 919 | 665 | 794 | 849 | 546 | 655 | 504 | |||||
Related Party | 4 | 2 | 2 | - | - | - | - | - | - | - | - | - | |||||
Preferred Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Preferred Stock Shares Authorized | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | |||||
Common Stock Shares Issued | 204 | 202 | 200 | 199 | 197 | 196 | 195 | 194 | 193 | 181 | 180 | 168 | |||||
Shares Outstanding | 196 | 195 | 193 | 191 | 190 | 190 | 189 | 188 | 187 | 175 | 174 | 161 | |||||
Treasury Stock Common Shares | 9 | 8 | 8 | 8 | 8 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -1.76% | 4.14% | - | - | - | - | - | - | - | - | - | - |
| 2025 | -8.46% | 14.58% | 27.70% | 5.18% | 1.71% | 10.26% | 2.24% | 14.53% | 14.47% | 0.34% | 12.36% | -3.19% |
| 2024 | 0.72% | -1.37% | -5.59% | -3.32% | 2.14% | -0.61% | 16.94% | 14.22% | 38.95% | -10.42% | -7.87% | -7.16% |
| 2023 | - | - | - | -7.54% | -15.05% | -23.46% | 9.88% | 52.53% | 36.11% | -17.98% | -20.15% | -13.39% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 1.52 | 2.77 | 3.88 | 5.19 | 4.57 | 4.67 | 3.19 | 4.59 | 5.54 | 3.32 | 5.54 | 3.93 | |||||
| Quick Ratio | 1.40 | 2.52 | 3.52 | 4.74 | 4.31 | 4.44 | 2.92 | 4.37 | 5.34 | 3.15 | 5.33 | 3.74 | |||||
| Working Capital | 424.93M | 509.78M | 622.78M | 736.42M | 543.07M | 566.29M | 305.36M | 481.87M | 641.95M | 333.75M | 481.61M | 322.76M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -1.60 | -1.45 | -1.51 | -1.60 | -1.54 | -1.63 | -1.53 | -1.72 | -1.80 | -1.41 | -1.55 | -1.36 | |||||
| Interest Coverage TTM | - | - | - | - | -30.42 | -12.78 | -8.16 | -5.87 | -5.68 | -7.47 | -6.90 | -6.59 | |||||
| Debt Ratio | 2.65 | 3.22 | 2.93 | 2.65 | 2.86 | 2.59 | 2.83 | 2.36 | 2.22 | 3.46 | 2.82 | 3.68 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.51 | 0.54 | 0.43 | 0.25 | 0.15 | 0.30 | 0.33 | 0.34 | 0.30 | 0.02 | 0.01 | 0.01 | |||||
| Days Sales Outstanding TTM | 100.85 | 52.40 | 120.21 | 118.98 | 330.19 | 5.32 | - | - | - | 68.70 | - | - | |||||
| Receivables Turnover TTM | 3.62 | 6.97 | 3.04 | 3.07 | 1.11 | 68.56 | - | - | - | 5.31 | - | - | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -3.73 | -3.83 | -4.16 | -4.08 | -3.52 | -2.88 | -2.36 | -2.44 | -3.02 | -3.95 | -3.79 | -3.61 | |||||
| Free Cash Flow Per Share TTM | -2.29 | -2.34 | -3.06 | -3.45 | -2.64 | -2.80 | -2.40 | -2.22 | -3.39 | -3.25 | -3.05 | -3.04 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 95.13% | 95.82% | 95.78% | 96.19% | 95.35% | 98.25% | 98.90% | 98.91% | 98.91% | 73.71% | 59.24% | 29.80% | |||||
| Operating Profit Margin TTM | -90.52% | -104.25% | -172.39% | -278.37% | -547.57% | -267.22% | -249.98% | -232.88% | -219.98% | -6,528.75% | -5,931.12% | -9,349.96% | |||||
| Net Profit Margin TTM | -125.42% | -145.98% | -225.59% | -329.68% | -525.22% | -241.44% | -203.94% | -208.49% | -246.67% | -6,913.92% | -6,560.01% | -10,199.44% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 355.17% | 126.26% | 62.46% | 7.62% | -41.71% | 2,285.27% | 2,209.77% | 3,761.22% | 181.05% | -88.02% | -89.37% | -93.74% | |||||
| Net Income Growth (1Y) | 8.69% | 36.80% | 79.71% | 70.17% | 24.11% | -16.70% | -28.19% | -21.07% | 27.33% | 32.71% | 23.32% | 10.21% | |||||
| EPS Growth (1Y) | 6.10% | 32.91% | 76.58% | 67.55% | 16.64% | -27.13% | -37.79% | -32.45% | 8.76% | 20.23% | 11.72% | 0.70% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -19.89 | -19.99 | -12.49 | -10.58 | -9.82 | -9.53 | -10.81 | -10.40 | -10.25 | -10.22 | -6.96 | -4.77 | |||||
| P/B | -6.38 | -7.06 | -5.15 | -4.60 | -4.01 | -3.50 | -3.90 | -4.35 | -5.26 | -4.89 | -3.60 | -2.03 | |||||
| P/S TTM | 24.94 | 29.18 | 28.17 | 34.89 | 51.59 | 23.01 | 22.04 | 21.68 | 25.28 | 706.43 | 456.77 | 486.56 | |||||
| Market Cap | 14.47B | 14.65B | 9.96B | 8.23B | 6.57B | 5.11B | 4.80B | 4.75B | 5.53B | 6.57B | 4.31B | 2.76B | |||||
| Enterprise Value | 13.58B | 14.08B | 9.32B | 7.48B | 6.03B | 4.86B | 4.83B | 4.78B | 5.48B | 6.62B | 4.22B | 2.90B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -445.12M | -448.60M | -587.52M | -658.18M | -502.26M | -521.66M | -451.54M | -416.49M | -604.92M | -529.03M | -497.82M | -488.08M | |||||
| Net Debt | -882.02M | -572.14M | -642.95M | -751.10M | -542.74M | -243.76M | 28.35M | 27.49M | -42.78M | 51.71M | -82.42M | 138.06M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data